Cohere Health is a Boston company founded in 2019 that automates prior authorisation and utilisation management for health insurers. Its models read clinical documentation, apply payer policy and approve routine requests instantly while routing genuinely complex cases to reviewers. The platform is used by national and regional plans to cut turnaround times that have long frustrated physicians and patients.
Robert Shepardson · Executive Officer · decision-maker
Siva Namasivayam · Executive Officer, Director · decision-maker
Duncan Reese · Executive Officer · decision-maker
Kristen Carucci · Executive Officer · decision-maker
Careers mailbox is known
Sep 28
Hiring 11 new roles, 17 closed in 14 days
Aug 11
Recognition Cohere Health Ranks 390 on the 2026 Inc. 5000 List of Fastest-Growing Private Companies, Marking Second Consecutive Year · PRNewswire
Oct 17, 2025
Partnership Cohere Health Teams Up with Microsoft to Advance Prior Authorization Using Ambient Listening · MedCity News
May 14, 2025
Raised a round Series C $90M
2019
Founded
60 open
+4 this week
closes in 57 d market 37
$148k stated pay, 23 roles
truth A 96
Veradermics is a dermatologist-founded, late clinical-stage biopharmaceutical company.
Tim Durso · Executive Officer · decision-maker
Dominic Carrano · Executive Officer · decision-maker
Mark Neumann · Executive Officer · decision-maker
Michael Greco · Executive Officer · decision-maker
No careers mailbox known
May 1
Raised a round Convertible Note $30M · SEC Form D
2020
Founded
Submit Connect Investigational Use Only. Products under development by Ventaris are investigational medical devices and are not approved or cleared by the U.S. Food and Drug Administration (FDA) or any other regulatory authority for commercial sale or use.
Surag Mantri · Executive Officer, Director · decision-maker
Varun Gupta · Director
Amir Abolfathi · Director
Justin Klein · Director
No careers mailbox known
Jan 6
Raised a round Venture round $30.7M · SEC Form D
2024
Founded
Perry Sternberg · Executive Officer, Director · decision-maker
Patrick Johnson · Executive Officer · decision-maker
Kenneth Widder · Executive Officer, Director · decision-maker
Greg Ostrow · Executive Officer, Director · decision-maker
Careers mailbox is known
Apr 3, 2025
Raised a round Convertible Note $20M · SEC Form D
2014
Founded
Quanta Therapeutics is pioneering allosteric modulation to directly restore conformational control of active RAS signaling at the cell membrane to inhibit the full scope of RAS-driven cancer types.
No named decision-maker yet.
Careers mailbox is known
Lassen Therapeutics is developing novel, best-in-class biotherapeutics to improve the lives of patients suffering from serious diseases.
No named decision-maker yet.
Careers mailbox is known
AEON is developing ABP-450, a proprietary botulinum toxin, to unlock the promise of therapeutic botulinum toxin to treat nervous system-related conditions.
No named decision-maker yet.
Careers mailbox is known
Novel treatment solutions to address Type 2 Diabetes for patients, providers and healthcare systems around the world. In partnership with Mayo Clinic.
Robert Kukujlan · Executive Officer · decision-maker
Michael Brenzel · Executive Officer · decision-maker
Robert Kukuljan · Executive Officer · decision-maker
Paul Hindrichs · Executive Officer, Director · decision-maker
Careers mailbox is known
Jan 14, 2025
New executive Endogenex Appoints Krissy Wright as Chief Financial Officer · PRNewswire
Jun 13, 2024
Raised a round Venture round $69.6M · SEC Form D
2017
Founded
onbelayhealthsolutions.com
We work with Independent Primary Care Practices, FQHC's, and Integrated Networks. Ensuring primary care teams succeed in value-based care.
No named decision-maker yet.
Careers mailbox is known
Sep 27
Moved to Rippling
Explore the future of inhaled therapy for COPD with AirNexis's innovative AN01 dry powder inhaler designed for ease of use.
No named decision-maker yet.
No careers mailbox known
Opna Bio is a clinical-stage biopharmaceutical company focused on the discovery and development of novel oncology therapeutics. The company’s lead program is OPN-6602, a dual EP300/CBP inhibitor, currently in a Phase 1 clinical trial in patients with multiple myeloma.
No named decision-maker yet.
Careers mailbox is known
2020
Founded
At Solta Medical, we deliver sophisitcated technology in a simple, elegant design.
No named decision-maker yet.
No careers mailbox known
Nalu Medical delivers an innovative, evidence-based therapy to treat chronic nerve pain safely and effectively.
No named decision-maker yet.
Careers mailbox is known
THE CLAUDIN-1 COMPANY Treat cancer and reverse fibrosis We are a clinical-stage biotech company with a mission to treat cancer and reverse fibrosis. To this end, we are rapidly advancing our pipeline of anti-Claudin-1 antibody-drug conjugates (ADCs) and monoclonal antibodies.
No named decision-maker yet.
Careers mailbox is known
2019
Founded
— Reshaping treatment for Functional Mitral Regurgitation (FMR) Transcatheter Leaflet Restoration (TLR) system is engineered to work in harmony with the native leaflets and the Mitral Valve apparatus to restore the function of the valve while preserving natural blood flow in patients with FMR.
No named decision-maker yet.
No careers mailbox known
There are over 60 million people with heart failure worldwide. It is the leading cause of hospitalization in people over 65.
No named decision-maker yet.
Careers mailbox is known
CAMPfield Therapeutics is a clinical-stage biopharmaceutical company developing prifemilast, a once-daily oral PDE4B-selective inhibitor for inflammatory bowel disease (IBD). Founded by the teams behind Entyvio®, Humira®, Otezla®, and Zeposia®.
No named decision-maker yet.
Careers mailbox is known
Sep 26
Posted 3 roles Clinical Trial Manager, Associate Director/Director, Clinical Supply Chain
Sep 17
2 roles crossed 45 days open
2026
Founded
Somatus is a leader in value-based kidney care working alongside health plans and providers to help prevent the progression of kidney disease.
Jon Kunkle · Executive Officer · decision-maker
Stacey Queen-Pyndell · Executive Officer · decision-maker
Ikenna Okezie · Executive Officer, Director · decision-maker
Alexander Houlday · Executive Officer · decision-maker
Careers mailbox is known
Jun 1, 2021
Raised a round Venture round $60.1M · SEC Form D
2017
Founded
Changing the trajectory of human health, one baby at a time.
Michael Johnson · Executive Officer, Director · decision-maker
Katharine Knobil · Director
Patrick Enright · Director
Roger Wyse · Director
Careers mailbox is known
May 21
Raised a round Venture round $39.2M · SEC Form D
2022
Founded
Important notice for Eargo customers: action required for your mobile app before October 22, 2026, plus support and warranty changes.
Adam Laponis · Executive Officer · decision-maker
Christian Gormsen · Executive Officer, Director · decision-maker
Raphael Michel · Director · decision-maker
William Brownie · Executive Officer · decision-maker
No careers mailbox known
2026
Team shrank to 116 was 162 · US Form 5500 (plan participants)
Jul 13, 2020
Raised a round Venture round $81.6M · SEC Form D
